Sensitivity to Mold Toxins

Mycotoxin sensitivity runs through multiple systems: HLA-DR variants shape how the immune system handles mold antigens, GSTM1 and GSTP1 shape Phase II clearance of the toxins themselves, and the broader inflammatory tone (TNF, IL-6 variants) shapes whether exposure produces measurable symptoms.

Carriers of specific HLA-DR haplotypes (notably the "biotoxin haplotypes" 4-3-53, 11-3-52B, 7-2-53) are associated with reduced ability to clear mold-related toxins and elevated risk of CIRS (Chronic Inflammatory Response Syndrome). Carriers of GSTM1-null variants are associated with slower toxin clearance. The pattern often presents as fatigue, brain fog, and inflammatory symptoms after a building or geographic move.

Reducing mold exposure is the highest-impact intervention: remediation of water-damaged buildings, avoiding chronically humid environments. Binders (cholestyramine, activated charcoal, bentonite) support toxin clearance through bile. Glutathione precursors and Phase II support help downstream. Saunas support skin clearance.

The "we moved into the rental and I haven't felt right since" or "the office building seems to make me sick" pattern often hides an HLA-DR variant that affects mold-toxin handling specifically. Which haplotype you carry decides whether mold investigation belongs early in a chronic-symptom workup or as a less-likely consideration.